Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Compare within a sector
MetricBSXBoston ScientificEWEdwards LifesciencesIDXXIdexx Laboratories
Snapshot
Price$49.92$90.03$596.54
Market cap$67.09B$54.34B$44.00B
Valuation
P/E20.8x47.2x43x
Forward P/E14.8x67.5x34.2x
Growth
Revenue growth17.4%13.8%13.1%
EPS growth74.7%-73.2%25.6%
Profitability
Net margin17.3%17.4%24.6%
ROE14.9%10.6%70.9%
Balance sheet & cash
Debt / equity0.47x0.06x0.53x
Free cash flow yield3.5%2.9%1.9%
Dividend yield———
Verdict
Investment ratingFavorable· 71Neutral· 47Favorable· 65

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearBSXtoday $50EWtoday $90IDXXtoday $597
2027$65.42 – $95.94+92% CAGR$68.87 – $101.01+12% CAGR$561.90 – $824.11+38% CAGR
2028$114.29 – $167.63+83% CAGR$70.25 – $103.03+7% CAGR$705.69 – $1,035.00+32% CAGR
2029$199.69 – $292.88+80% CAGR$71.66 – $105.09+5% CAGR$886.27 – $1,299.86+30% CAGR
2030$348.90 – $511.73+79% CAGR$73.09 – $107.20+4% CAGR$1,113.07 – $1,632.50+29% CAGR
2031$609.61 – $894.09+78% CAGR$74.55 – $109.34+4% CAGR$1,397.90 – $2,050.25+28% CAGR
5-yr CAGR65.0% – 78.1%-3.7% – 4.0%18.6% – 28.0%